Insider Trading & Ownership of Christopher Thomas Giordano

Location
Morrisville, NC
Summary
The estimated net worth of Christopher Thomas Giordano is at least $4,073,445 dollars as of 13 Jan 2026. Christopher Thomas Giordano is the CEO, Director of TENAX THERAPEUTICS, INC. and owns shares of TENAX THERAPEUTICS, INC. (TENX) stock worth about $4.07M.
Signature
/s/ S. Halle Vakani, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Christopher Thomas Giordano and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Christopher Thomas Giordano has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $4,073,445.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: TENAX THERAPEUTICS, INC. ($4,073,445).
  • Past-year value change for that position: +$20,000.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Christopher Thomas Giordano

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TENX TENAX THERAPEUTICS, INC. CEO, Director $4,073,445 +$20,000 +0.49% 09 Jan 2026

Insider Transactions Reported by Christopher Thomas Giordano:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored